東和薬品の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2023/02/24 | 1,918 | 1,918 | 1,892 | 1,897 | -14 | -0.7% | 127,800 |
2023/02/22 | 1,915 | 1,920 | 1,898 | 1,911 | -18 | -0.9% | 105,600 |
2023/02/21 | 1,902 | 1,932 | 1,897 | 1,929 | +21 | +1.1% | 112,300 |
2023/02/20 | 1,916 | 1,919 | 1,903 | 1,908 | +6 | +0.3% | 63,700 |
2023/02/17 | 1,919 | 1,922 | 1,902 | 1,902 | -26 | -1.3% | 103,600 |
2023/02/16 | 1,938 | 1,949 | 1,927 | 1,928 | -1 | -0.1% | 74,800 |
2023/02/15 | 1,950 | 1,951 | 1,913 | 1,929 | -13 | -0.7% | 119,300 |
2023/02/14 | 1,950 | 1,951 | 1,904 | 1,942 | -30 | -1.5% | 239,600 |
2023/02/13 | 1,985 | 1,986 | 1,960 | 1,972 | -14 | -0.7% | 98,100 |
2023/02/10 | 1,990 | 2,003 | 1,985 | 1,986 | -9 | -0.5% | 55,100 |
2023/02/09 | 1,998 | 2,013 | 1,991 | 1,995 | -7 | -0.3% | 46,400 |
2023/02/08 | 2,003 | 2,015 | 1,995 | 2,002 | -1 | ±0% | 54,700 |
2023/02/07 | 2,005 | 2,008 | 1,997 | 2,003 | +7 | +0.4% | 24,100 |
2023/02/06 | 1,999 | 2,005 | 1,992 | 1,996 | -3 | -0.2% | 41,100 |
2023/02/03 | 2,003 | 2,011 | 1,987 | 1,999 | -13 | -0.6% | 66,900 |
2023/02/02 | 2,032 | 2,033 | 2,011 | 2,012 | -19 | -0.9% | 56,600 |
2023/02/01 | 2,059 | 2,059 | 2,030 | 2,031 | -17 | -0.8% | 42,100 |
2023/01/31 | 2,033 | 2,054 | 2,031 | 2,048 | +16 | +0.8% | 48,600 |
2023/01/30 | 2,026 | 2,048 | 2,026 | 2,032 | +8 | +0.4% | 56,500 |
2023/01/27 | 2,050 | 2,050 | 2,022 | 2,024 | -16 | -0.8% | 42,800 |
2023/01/26 | 2,040 | 2,045 | 2,029 | 2,040 | -4 | -0.2% | 39,100 |
2023/01/25 | 2,070 | 2,070 | 2,040 | 2,044 | -20 | -1% | 54,500 |
2023/01/24 | 2,061 | 2,075 | 2,055 | 2,064 | +20 | +1% | 46,000 |
2023/01/23 | 2,045 | 2,059 | 2,040 | 2,044 | +6 | +0.3% | 45,100 |
2023/01/20 | 2,023 | 2,040 | 2,020 | 2,038 | +12 | +0.6% | 31,400 |
2023/01/19 | 2,035 | 2,035 | 2,017 | 2,026 | -15 | -0.7% | 35,900 |
2023/01/18 | 2,008 | 2,042 | 2,008 | 2,041 | +36 | +1.8% | 55,700 |
2023/01/17 | 2,001 | 2,017 | 1,999 | 2,005 | -2 | -0.1% | 58,900 |
2023/01/16 | 2,001 | 2,023 | 1,999 | 2,007 | -6 | -0.3% | 49,600 |
2023/01/13 | 2,008 | 2,024 | 1,983 | 2,013 | +3 | +0.1% | 137,100 |
2023/01/12 | 2,012 | 2,022 | 2,008 | 2,010 | -4 | -0.2% | 54,300 |
2023/01/11 | 2,027 | 2,034 | 2,012 | 2,014 | ±0 | ±0% | 84,100 |
2023/01/10 | 2,039 | 2,040 | 2,003 | 2,014 | -7 | -0.3% | 98,200 |
2023/01/06 | 2,043 | 2,049 | 2,021 | 2,021 | -22 | -1.1% | 76,300 |
2023/01/05 | 2,066 | 2,071 | 2,043 | 2,043 | -25 | -1.2% | 58,700 |
2023/01/04 | 2,130 | 2,130 | 2,067 | 2,068 | -63 | -3% | 57,700 |
2022/12/30 | 2,144 | 2,156 | 2,131 | 2,131 | -4 | -0.2% | 43,900 |
2022/12/29 | 2,127 | 2,143 | 2,115 | 2,135 | +3 | +0.1% | 60,400 |
2022/12/28 | 2,123 | 2,132 | 2,109 | 2,132 | +7 | +0.3% | 46,400 |
2022/12/27 | 2,101 | 2,125 | 2,101 | 2,125 | +22 | +1% | 58,800 |
2022/12/26 | 2,129 | 2,129 | 2,099 | 2,103 | -26 | -1.2% | 45,200 |
2022/12/23 | 2,110 | 2,129 | 2,102 | 2,129 | +25 | +1.2% | 68,100 |
2022/12/22 | 2,090 | 2,108 | 2,071 | 2,104 | +21 | +1% | 60,400 |
2022/12/21 | 2,097 | 2,097 | 2,072 | 2,083 | -12 | -0.6% | 89,900 |
2022/12/20 | 2,110 | 2,133 | 2,078 | 2,095 | -15 | -0.7% | 102,300 |
2022/12/19 | 2,130 | 2,130 | 2,105 | 2,110 | -34 | -1.6% | 55,100 |
2022/12/16 | 2,143 | 2,161 | 2,137 | 2,144 | -23 | -1.1% | 78,000 |
2022/12/15 | 2,148 | 2,169 | 2,146 | 2,167 | +25 | +1.2% | 70,100 |
2022/12/14 | 2,140 | 2,150 | 2,133 | 2,142 | +11 | +0.5% | 42,400 |
2022/12/13 | 2,121 | 2,138 | 2,121 | 2,131 | +12 | +0.6% | 68,100 |
301~
350
件表示中 / 6710件
類似銘柄と比較する
現在ご覧いただいている「東和薬品」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
東和薬品 | 274,000円 | +14.7% | -28.1% | 2.19% | 11.63倍 | 0.87倍 |
|
後発医薬品メーカーで国内2強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
科研薬 | 345,100円 | +4.2% | -21.6% | 4.35% | 23.34倍 | 0.91倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
キッセイ薬 | 316,000円 | +9.8% | -12.1% | 2.85% | 12.36倍 | 0.63倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
住友ファーマ | 33,600円 | +7.5% | - | 0.00% | - | 0.86倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
ネクセラファーマ | 146,800円 | +150.7% | - | 0.00% | 37.71倍 | 1.98倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
市場注目の銘柄
チャート関連のコラム